Clinica Baviera (D9Z) Stock Statistics & Valuation Metrics
Total Valuation
Clinica Baviera has a market cap or net worth of EUR 867.34M. The enterprise value is EUR 882.45M.
- Market Cap
- EUR 867.34M
- Enterprise Value
- EUR 882.45M
Share Statistics
Clinica Baviera has 16,307,580 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 16,307,580
- Owned by Insiders
- ―
- Owned by Institutions
- 1.09%
Financial Efficiency
Clinica Baviera’s return on equity (ROE) is 0.38 and return on invested capital (ROIC) is 29.49%.
- Return on Equity (ROE)
- 0.38
- Return on Assets (ROA)
- 0.17
- Return on Invested Capital (ROIC)
- 29.49%
- Return on Capital Employed (ROCE)
- 0.44
- Revenue Per Employee
- 150.22K
- Profits Per Employee
- 20.94K
- Employee Count
- 2,009
- Asset Turnover
- 1.22
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Clinica Baviera is 19.00. Clinica Baviera’s PEG ratio is 1.42.
- PE Ratio
- 19.00
- PS Ratio
- 2.68
- PB Ratio
- 7.61
- Price to FCF
- 17.53
- Price to Operating Cash Flow
- 10.76
- PEG Ratio
- 1.42
Income Statement
In the last 12 months, Clinica Baviera had revenue of 301.78M and earned 42.06M in profits. Earnings per share was 2.63.
- Revenue
- 301.78M
- Gross Profit
- 127.08M
- Operating Income
- 82.24M
- Pretax Income
- 60.11M
- Net Income
- 42.06M
- EBITDA
- 106.14M
- Earnings Per Share (EPS)
- 2.63
Cash Flow
In the last 12 months, operating cash flow was 78.89M and capital expenditures -30.43M, giving a free cash flow of 48.46M billion.
- Operating Cash Flow
- 78.89M
- Free Cash Flow
- 48.46M
- Free Cash Flow per Share
- 3.03
Dividends & Yields
Clinica Baviera pays an annual dividend of ―, resulting in a dividend yield of 3.00%
- Dividend Per Share
- ―
- Dividend Yield
- 3.00%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 5.70%
- Earnings Yield
- 5.46%
Stock Price Statistics
- Beta
- 0.69
- 52-Week Price Change
- 24.77%
- 50-Day Moving Average
- 56.39
- 200-Day Moving Average
- 54.53
- Relative Strength Index (RSI)
- 42.85
- Average Volume (3m)
- 21
Important Dates
Clinica Baviera upcoming earnings date is Nov 05, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Jul 29, 2026
- Next Earnings Date
- Nov 05, 2026
- Ex-Dividend Date
- ―
Financial Position
Clinica Baviera as a current ratio of 0.96, with Debt / Equity ratio of 62.88%
- Current Ratio
- 0.96
- Quick Ratio
- 0.96
- Debt to Market Cap
- 0.01
- Net Debt to EBITDA
- 0.60
- Interest Coverage Ratio
- 36.05
Taxes
In the past 12 months, Clinica Baviera has paid 17.18M in taxes.
- Income Tax
- 17.18M
- Effective Tax Rate
- 0.29
Enterprise Valuation
Clinica Baviera EV to EBITDA ratio is 9.28, with an EV/FCF ratio of 17.53.
- EV to Sales
- 2.68
- EV to EBITDA
- 9.28
- EV to Free Cash Flow
- 17.53
- EV to Operating Cash Flow
- 10.77
Balance Sheet
Clinica Baviera has EUR 51.59M in cash and marketable securities with EUR 9.90M in debt, giving a net cash position of EUR 41.70M billion.
- Cash & Marketable Securities
- EUR 51.59M
- Total Debt
- EUR 9.90M
- Net Cash
- EUR 41.70M
- Net Cash Per Share
- EUR 2.56
- Tangible Book Value Per Share
- EUR 4.44
Margins
Gross margin is 82.14%, with operating margin of 20.38%, and net profit margin of 14.62%.
- Gross Margin
- 82.14%
- Operating Margin
- 20.38%
- Pretax Margin
- 20.44%
- Net Profit Margin
- 14.62%
- EBITDA Margin
- 28.87%
- EBIT Margin
- 20.68%
Analyst Forecast
The average price target for Clinica Baviera is EUR 71.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- EUR 71.50
- Price Target Upside
- 33.90% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 1
- Revenue Growth Forecast
- 10.89%
- EPS Growth Forecast
- 17.12%
